Results 1 to 10 of about 3,209,259 (263)
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Nature, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.2.12.1, BA.4 and BA.5 exhibit higher transmissibility than the BA.2 lineage1.
Yunlong Cao, Fanchong Jian, Shuo Du
exaly +2 more sources
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature, 2020 The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health1 and the medical countermeasures available so far are limited2,3.
Elaine C Chen +2 more
exaly +2 more sources
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Nature, 2021 Jianliang Xu +2 more
exaly +2 more sources
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Nature, 2020 Jinfang Yu, Jincun Zhao, Jiwan Ge
exaly +2 more sources
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Nature, 2020 David D Ho, Manoj S Nair, Yaoxing Huang
exaly +2 more sources
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Nature, 2021 The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies requires immediate investigation.
Yunlong Cao +29 more
semanticscholar +1 more source
bioRxiv, 2021 The evolution of SARS-CoV-2 could impair recognition of the virus by human antibody-mediated immunity. To facilitate prospective surveillance for such evolution, we map how convalescent serum antibodies are impacted by all mutations to the spike’s ...
Allison J. Greaney +6 more
semanticscholar +1 more source
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
New England Journal of Medicine, 2020 Coagulopathy in Critical Illness with Covid-19 The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit ...
Yan Zhang +34 more
semanticscholar +1 more source
Peptides, Antibodies, Peptide Antibodies and More [PDF]
International Journal of Molecular Sciences, 2019 The applications of peptides and antibodies to multiple targets have emerged as powerful tools in research, diagnostics, vaccine development, and therapeutics. Antibodies are unique since they, in theory, can be directed to any desired target, which illustrates their versatile nature and broad spectrum of use as illustrated by numerous applications of ...
Nicole Trier, Paul Hansen, Gunnar Houen
openaire +5 more sources
Neutralizing monoclonal antibodies for treatment of COVID-19
Nature reviews. Immunology, 2021 Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical trials.
P. Taylor +5 more
semanticscholar +1 more source